KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Issued (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Shares Issued for 6 consecutive years, with $355000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 106.51% year-over-year to $355000.0, compared with a TTM value of $756000.0 through Dec 2025, down 30.26%, and an annual FY2025 reading of $756000.0, down 30.26% over the prior year.
  • Shares Issued was $355000.0 for Q4 2025 at Aurinia Pharmaceuticals, up from -$8.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $196.7 million in Q4 2021 and bottomed at -$8.9 million in Q2 2025.
  • Average Shares Issued over 5 years is $11.4 million, with a median of $875000.0 recorded in 2023.
  • The sharpest move saw Shares Issued soared 1400.0% in 2021, then plummeted 1556.89% in 2025.
  • Year by year, Shares Issued stood at $196.7 million in 2021, then plummeted by 99.92% to $167000.0 in 2022, then soared by 735.33% to $1.4 million in 2023, then tumbled by 490.9% to -$5.5 million in 2024, then surged by 106.51% to $355000.0 in 2025.
  • Business Quant data shows Shares Issued for AUPH at $355000.0 in Q4 2025, -$8.9 million in Q2 2025, and $9.3 million in Q1 2025.